Therefore, the significantly elevated CRP may reflect the severity of inflammation, whereas lymphopenia is associated with suppressed immune function and adverse outcomes of COVID-19 patients, and CLR may be more sensitive in capturing the early part of the inflammatory cascade than other biomarkers as previously reported (19, 21, 26–28). Here, CRP is linked to COVID-19.